Health Equity in Clinical Trials Congress | May 8 - 9, 2024

The First Dedicated Health Equity Conference Spanning the Clinical Trial Ecosystem

Receive the implementable tools to improve DEI recruitment and retention in clinical trials through case-study panel discussions and presentations.

Understand how to refine your data-driven approach to clinical trial diversity by incorporating real world evidence, technology, and patient communications.

Deliver sustainable community engagement efforts across your clinical trials and expand your collaboration efforts across social and healthcare ecosystems.

Including Smaller Drug Developers

Biotechs and small pharma are often falling behind with diversity in clinical trials, we aim to create collaboration with these companies to ensure health equity is front of mind across the industry.

FIND OUT MORE

Industry Accountability & Alignment

Targeting structural and systemic barriers can only be achieved if we hold the entire
system accountable for creating action whilst providing the industry with the solutions to create real change.

FIND OUT MORE

Lifting Up All Voices and Communities

From patients to the diversity heads of pharmaceutical giants, we explore
every level of health equity action whilst platforming advocates of all under-served
communities.

FIND OUT MORE

AUDIENCE BREAKDOWN

Pharmaceutical & Biotech Companies

This event provides a non-competitive space for leading industry companies to platform their health equity strategy successes and discuss the next steps needed to improve health equity action.
REGISTER NOW

45%
Clinical Trial Service Providers

Discover the innovations being made to improve health equity action from CROs, AI companies, data analytics companies, alternative care models and medtech companies.
REGISTER NOW

20%
Research Sites & Academic Institutions

Meet principal investigators and the workforce conducting clinical research, learn how to educate communities and engage with hard-to-reach populations.
REGISTER NOW

20%
Patient Advocacy Groups & Non-Profits

Discuss the actors required to adapt a patient-centric approach to health equity in clinical trials and implement minority patient voices throughout the entire process.
REGISTER NOW

12%
Regulatory & Government Agencies

Meet the high-level bodies that influence health equity progression and understand the best practices from the FDA diversity plan submission and post market analyses.
REGISTER NOW

3%

TRAILBLAZING SPEAKERS

Kim Fookes

Global Head, Diversity & Inclusion in Clinical Trials

Novartis

Sandra Amaro

Head of Clinical Trial Diversity

Pfizer

Tabia Henry Akintobi

Associate Dean for Community Engagement, Principal Investigator

Morehouse School of Medicine

Martin Mendoza

Director of Health Equity

National Institute of Health

Rajbir Singh

Principal Investigator

Meharry Medical College

Edie Stringfellow

Vice President of Ecosystem Development

Center for Global Health Innovation

DOWNLOAD PROGRAM

RESEARCH HUB

PRESENT DISRUPTIVE HEALTH EQUITY RESEARCH & DEVELOPMENT

New for 2024, we are launching the Health Equity Research Hub! This expands the scope of our shared solutions to include innovative approaches to clinical trial recruitment and community engagement. Showcase a poster on your research to our full-ecosystem audience as we ensure industry DEI intiatives deploy the most effective strategies.

Requirements

Applicants must purchase a Congress ticket and represent academic institutions, trial sites, non-profits or advocacy groups.
Requires a paper to have been submitted or published on topics relating to diversity, equity or inclusion in clinical trials.
20 limited spaces are available on a first-come first-served basis, applications will not be accepted when at full capacity.

APPLY HERE

Main Event Days

50+

Industry Leading Speakers

350+

Industry Experts

10+

Dedicated Networking Hours

Key Agenda Highlights

Jump to: Day 1 | Day 2

Printable version

Wednesday, 8 May, 2024

Patient Perspectives: Progressing Health Equity and Empowering Underserved Communities

Patients are the quality control of health equity developments, sharing experiences of clinical trial participation, highlighting the successes of improved patient experience.
What can the industry learn from patient experts, discussing the implementation of patient voice into health equity strategic programs.
Includes an open Q&A towards the end of the panel to ask critical questions to patients and facilitate industry learning.

Author:

Allison Kalloo

Patient Advocate & CEO

Clinical Ambassador

Author:

Sabina Kineen

Rare Disease Patient, Caregiver, Advocate

From Competitors to Collaborators: Co-operative Pharmaceutical Developments & Health Equity Solutions

Platforming the tangible successes pharmaceutical companies are having to improve DEI in clinical trials.
Highlighting data-driven strategies to improve site capabilities for underserved-patient engagement, recruitment, and experience.
The importance of collaboration and standardization from a large-scale initative perspective, where are we at and where do we need to be.

Author:

Michel Reid

Global Head of Demographics & Diversity

GSK

Author:

Alana Miller

Associate Director, Diversity in Clinical Trials

Merck

Author:

Monique Adams

Executive Director, Diversity & Inclusion in Clinical Trials

Sanofi

Thursday, 9 May, 2024

Data Driven Solutions and Successes for Clinical Trial Diversity

Discussing implementation of RWE in upstream and downstream clinical operations to improve diversity strategy.
Platforming cases of qualitative data retrieval and how this aids understanding of under-served populations.

Author:

Mary Nwokedi

Director, Clinical Trial Diversity: Science and Regulatory Advocacy

PhRMA

Author:

Kemi Willaims

Senior Director, Patient Science

AstraZeneca

Centering Health Equity in Clinical Trial Design

How are we ensuring under-served patient populations voices are considered in trial format?
Optimizing both population data and clinical data analytics to develop accessible and equitable clinical trials.

Author:

Brittany Gerald

Senior Manager Sr. Manager, Clinical Trial Diversity and Inclusion, Patient and Site Experience (PASE)

Moderna

Author:

Benjamin Young

Senior Global Medical Director

ViiV Healthcare

Author:

Sandra Amaro

Head of Clinical Trial Diversity

Pfizer

Jump to: Day 1 | Day 2

PREVIOUS INDUSTRY LEADING SPEAKERS

Monique Adams

Executive Director, Diversity & Inclusion in Clinical Trials

Sanofi

Sandra Amaro

Head of Clinical Trial Diversity

Pfizer

Tabia Henry Akintobi

Associate Dean for Community Engagement, Principal Investigator

Morehouse School of Medicine

Martin Mendoza

Director of Health Equity

National Institute of Health

Rajbir Singh

Principal Investigator

Meharry Medical College

Edie Stringfellow

Vice President of Ecosystem Development

Center for Global Health Innovation

Michel Reid

Global Head of Demographics & Diversity

GSK

Kemi Willaims

Senior Director, Patient Science

AstraZeneca

Mary Nwokedi

Director, Clinical Trial Diversity: Science and Regulatory Advocacy

PhRMA

LaTrisha Horne

Associate Director of Precision Medicine Implementation

Morehouse School of Medicine

Benjamin Young

Senior Global Medical Director

ViiV Healthcare

Keri Norris

Vice President, Health Equity & DEI

National Blood Disorders Foundation

Wenora Johnson

Patient Expert

Grayson Schultz

Patient Expert

Alana Miller

Associate Director, Diversity in Clinical Trials

Merck

Donald Alcendor

Director of Research

Meharry Medical College

Kimberly Doggett

Senior Director, Clinical Trial Diversity

BeiGene

Savine DaCosta

Clinical Trial Diversity Lead

Biogen

Brittany Gerald

Senior Manager Sr. Manager, Clinical Trial Diversity and Inclusion, Patient and Site Experience (PASE)

Moderna

Gabrielle Jones

Vice President, Community Engagement & Advocacy

HEAL COLLABORATIVE

Renarda Jones

Chief Executive Officer

Diverse Research Now

Keith Dawson

Principal Global Health Equity & Population Science

Genentech

Amy Ben-Arieh

Director of Research Compliance

Fenway Health

Lashell Robinson

Director, Diversity & Inclusion in Clinical Trials

Takeda Pharmaceuticals

Rachel Barron

Senior Manager, Health Equity

Global Genes

Keri Norris

Vice President, Health Equity & DEI

National Blood Disorders Foundation

Carla Tardif

CEO

Family Reach

Yamile Molina

Director of Community Engagement

University of Illinois Cancer Center

Terri Wiggins

Senior Vice President, Health Equity

American Diabetes Association

Dan Hartman

Director, Integrated Development

Bill & Melinda Gates

Adrian Kielhorn

Senior Director, HEOR

Alexion Pharmaceuticals

O.B. Gray

Executive Vice President

Proximity Health Solutions

Shanelle Gabriel

Patient Advocate

Allison Kalloo

Patient Advocate & CEO

Clinical Ambassador

Quincy Byrdsong

Vice President of Research Operations

Ballad Health

Sabina Kineen

Rare Disease Patient, Caregiver, Advocate

Tracey Newman

Vice President, Global Programs and Diversity in Clinical Trials Research

National Medical Fellowships

Laveina Dash

Director, Diversity in Clinical Research Programs

National Medical Fellowships

Roy Reese

Senior Advisor

Ichor Strategies

Sandra Torres

Executive Director, Patient Engagement, Marketing & Diversity

K2 Medical Research

Jennifer Cunningham-Erves

Associate Professor and Director of Community Engaged Research

Vanderbilt University Medical Center

Anastacia Awad

Executive Director, Head of Diversity, Equity & Inclusion for R&D

Novartis

Gary Cobb

Head of Diversity & Inclusion in Clinical Trials, U.S.

Boehringer Ingelheim

Kevin Aniskovich

CEO

Jumo Health

Tony Wafford

President & CEO

I Choose Life Foundation

Erika Heiges

Patient Engagement & Recruitment Lead, Global Development Operations

Bristol Myers Squibb

Gwenn Oakes

Principal Scientist, Global Trial Optimization

Merck

Maimah Karmo

Chief Executive Officer & President

Tigerlily Foundation

Nicole Keidel

Clinical Trials Senior Advisor

Evernorth

Melanie Igwe

Co-Founder & COO

ViuHealth

+ See More

The inaugural Health Equity Congress brought colleagues from across the industry together for the first time. It was wonderful to hear successes, best practices and how we could all continue to work together.

LaShell Robinson, Director, Diversity & Inclusion in Clinical Trials, Takeda Pharmaceuticals

By far one of the best congresses I have attended on this topic. The insights gained from each session were valuable.

Wanda Hill, VP, GSK

It was so energizing being amongst the health equity thought and practice leaders from across the globe!

Leigh Boehmer, Chief Medical Officer, Association of Community Cancer Centers

Fantastic speakers who were able to illuminate tangible things we can be doing *NOW* to make a difference, as well as sharing the path ahead.

Sarah Friedhoff, Director, Patient Advocacy, Astria Therapeutics

I felt privileged to be part of this conversation and to hear from and meet such an accomplished group of people.

Margarita Nunez MD, Principal Investigator, Synexus / Accelerated Enrollment Solutions (AES) New York

The Health Equity in Clinical Trials Congress was the most productive and actionable meeting on the topic that I’ve attended. Not only was I able to hear tangible, real life successes and failures; but I had the opportunity to pick the brains of some of the brightest in the space in Industry.

Jocelyn Ashford, Head of US Corporate Affairs, AstraZeneca

OUR SELECTION COMITTEE

Author:

Brannon Morisoli

Director

SWK Holdings

Mr. Morisoli joined SWK Holdings as a Senior Analyst in March 2016. Prior to joining SWK, he was an Investment Analyst and Portfolio Manager for a family office that invested in equities, fixed income, real estate, and alternative investments. Prior to that, he was an Investment Analyst for Presidium Group, a real estate private equity firm, where he played an integral role in closing over $100mm in transactions. Mr. Morisoli began his career at Neurografix, a startup medical technology company in Santa Monica, CA that was doing groundbreaking work in the MRI imaging of peripheral nerves. While with Neurografix, he was published in two leading neurology journals. Brannon graduated from UCLA with a B.S., was awarded a fellowship and graduated from the University of Notre Dame with an M.B.A, and was awarded a Samson Fellowship from the University of Wisconsin Law School, where he graduated with a J.D. Mr. Morisoli is an inactive member of the State Bar of Wisconsin

Author:

Thomas Busby

Vice President

Outcome Capital

Thomas Busby is a Vice President and has been with Outcome Capital since 2015. He focuses on medical technology, digital health and life science services segments with particular interest in innovative life science companies that deliver patient impact by leveraging novel approaches. Thomas is driven by the desire to identify disruptive technologies and services that require unique strategic thought and assistance to realize their full market potential. Thomas has been published in leading life science journals Life Science Leader and The Pharma Letter, and also serves on the board of HealthTech Build, a Boston-based digital health innovation group.

Prior to his career in life-science investment banking, Thomas pursued his passion for the public service and non-profit sectors working in a variety of leadership and management positions, and at one time held a Massachusetts teaching license.

Thomas completed his MBA at Suffolk University’s Sawyer Business School on full academic scholarship where he was President of the school’s Graduate Business Association and class speaker at graduation. Prior, he completed a BS in Philosophy with Honors from Suffolk’s College of Arts & Sciences. Committed to giving back, Thomas is currently the President of the College of Arts & Sciences Alumni Board of Directors. Thomas is a FINRA Registered Securities Representative holding his Series 79 and 63.

Author:

Robert Crousore

Managing Partner

Health Frontier Ventures

Robert has 28 years of experience in the health care products and
services industry. Crousore is a serial entrepreneur with multiple
successful product and services company exits. His experience spans
the entire business enterprise including Sales, Marketing, Operations,
Product Innovation and, most recently M & A.

Highlights Include:

Has successfully managed a global commercial organization in the wound care business.
Has a number of patent credits for products in the wound care industry.
Sits on multiple boards of healthcare technology companies.
His passion is creating meaningful changes in patient care by combining great products with great teams that are focused on empowering improved clinical and financial outcomes.

Author:

Brannon Morisoli

Director

SWK Holdings

Author:

Thomas Busby

Vice President

Outcome Capital

Author:

Robert Crousore

Managing Partner

Health Frontier Ventures

Highlights Include:

Has successfully managed a global commercial organization in the wound care business.
Has a number of patent credits for products in the wound care industry.
Sits on multiple boards of healthcare technology companies.
His passion is creating meaningful changes in patient care by combining great products with great teams that are focused on empowering improved clinical and financial outcomes.

DOWNLOAD THE AGENDA

"It was so energizing being amongst health equity thought and practice leaders from across the globe!"

- Leigh Boehmer, Chief Medical Officer, Association of Community Cancer Centers

Our program platforms case-studies, data-driven solutions, and best practices from across the clinical trials ecosystem to innovate health equity approaches and facilitate collaborative action.

Receive the implementable tools to operationalize clinical trial diversity strategy and innovate the health equity lens applied in your role, at your organization

Network with 400+ senior executives driving forward the health equity mission and 200+ clinical trial decision-makers to center health equity in your collaboration and partnership considerations

Unlock new health equity approaches and optimize your initiatives as we platform all voices across the industry and delve into operational developments, network construction, data strategies, community engagement, patient trust, accessibility, and the role of technology

Jump to: Day 1 | Day 2

Printable version

Wednesday, 8 May, 2024

Patient Perspectives: Progressing Health Equity and Empowering Underserved Communities

Patients are the quality control of health equity developments, sharing experiences of clinical trial participation, highlighting the successes of improved patient experience.
What can the industry learn from patient experts, discussing the implementation of patient voice into health equity strategic programs.
Includes an open Q&A towards the end of the panel to ask critical questions to patients and facilitate industry learning.

Author:

Allison Kalloo

Patient Advocate & CEO

Clinical Ambassador

Author:

Sabina Kineen

Rare Disease Patient, Caregiver, Advocate

From Competitors to Collaborators: Co-operative Pharmaceutical Developments & Health Equity Solutions

Platforming the tangible successes pharmaceutical companies are having to improve DEI in clinical trials.
Highlighting data-driven strategies to improve site capabilities for underserved-patient engagement, recruitment, and experience.
The importance of collaboration and standardization from a large-scale initative perspective, where are we at and where do we need to be.

Author:

Michel Reid

Global Head of Demographics & Diversity

GSK

Author:

Alana Miller

Associate Director, Diversity in Clinical Trials

Merck

Author:

Monique Adams

Executive Director, Diversity & Inclusion in Clinical Trials

Sanofi

Thursday, 9 May, 2024

Data Driven Solutions and Successes for Clinical Trial Diversity

Discussing implementation of RWE in upstream and downstream clinical operations to improve diversity strategy.
Platforming cases of qualitative data retrieval and how this aids understanding of under-served populations.

Author:

Mary Nwokedi

Director, Clinical Trial Diversity: Science and Regulatory Advocacy

PhRMA

Author:

Kemi Willaims

Senior Director, Patient Science

AstraZeneca

Centering Health Equity in Clinical Trial Design

How are we ensuring under-served patient populations voices are considered in trial format?
Optimizing both population data and clinical data analytics to develop accessible and equitable clinical trials.

Author:

Brittany Gerald

Senior Manager Sr. Manager, Clinical Trial Diversity and Inclusion, Patient and Site Experience (PASE)

Moderna

Author:

Benjamin Young

Senior Global Medical Director

ViiV Healthcare

Author:

Sandra Amaro

Head of Clinical Trial Diversity

Pfizer

Jump to: Day 1 | Day 2

DOWNLOAD THE PROGRAM

CONFERENCE PACKAGES

Registration ends in

— May 10, 2024 —

Monday, April 15, 2024 to Friday, May 10, 2024

Tier 1: Trial Sites, Healthcare Centers, Academics, Advocacy Groups, Non-profits

$799

+ Register Now

Patient Facing Healthcare Centers and Charitable Patient Groups

Monday, April 15, 2024 to Friday, May 10, 2024

Tier 2: Pharma and Biotech

$2,599

+ Register Now

Must have an active pipeline

Monday, April 15, 2024 to Friday, May 10, 2024

Tier 3: Solution Providers & CROs

$3,499

+ Register Now

Organizations that offer paid-for products and services, including but not limited to: Consultants, CROs, Data Analytics Providers, Patient Engagement and Recruitment

Preparing registration...

Venue Description

Venue

The Westin Peachtree Plaza, 210 Peachtree St. NW, Atlanta, GA, 30303

We're excited to welcome you face-to-face in Atlanta at the Westin Peachtree Plaza for the Health Equity in Clinical Trials Congress!

BOOK LOCAL ACCOMMODATION HERE

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Contact Us

Kisaco Research
Registered office address: 41a Maltby Street, London, SE1 3PA
+44 (0)20 3696 2920 | [email protected]
Place of registration: London, United Kingdom
Company number: 09316521

We need some information to know how best to respond to your request below.

Email *

First Name *

Last Name *

Company *

Permission

Yes, I would like to receive news and information from Kisaco Events.

Topics Interested In *

Message

s79kkfi3w1 To prevent automated spam submissions leave this field empty.

Leave this field blank

Subject Access Requests: If you would like a copy of the data/information we hold about you, please email [email protected].

User Deletion Request: If you wish to have your information that is held by Kisaco Research deleted, please email [email protected].

For more information on Kisaco Research policy and procedures, please visit our Privacy Policy.

2nd Health Equity in Clinical Trials Congress | 2024 | Atlanta

The First Dedicated Health Equity Conference Spanning the Clinical Trial Ecosystem

HOW TO GET INVOLVED

PARTNER WITH US

REGISTER YOUR INTEREST

Including Smaller Drug Developers

Industry Accountability & Alignment

Lifting Up All Voices and Communities

AUDIENCE BREAKDOWN

THE 5 CONGRESS PILLARS

TRAILBLAZING SPEAKERS

Kim Fookes

Kim Fookes

Kim Fookes

Sandra Amaro

Sandra Amaro

Sandra Amaro

Tabia Henry Akintobi

Tabia Henry Akintobi

Tabia Henry Akintobi

Martin Mendoza

Martin Mendoza

Martin Mendoza

Rajbir Singh

Rajbir Singh

Rajbir Singh

Edie Stringfellow

Edie Stringfellow

Edie Stringfellow

RESEARCH HUB

Key Agenda Highlights

Patient Perspectives: Progressing Health Equity and Empowering Underserved Communities

Author:

Allison Kalloo

Author:

Sabina Kineen

From Competitors to Collaborators: Co-operative Pharmaceutical Developments & Health Equity Solutions

Author:

Michel Reid

Author:

Alana Miller

Author:

Monique Adams

Data Driven Solutions and Successes for Clinical Trial Diversity

Author:

Mary Nwokedi

Author:

Kemi Willaims

Centering Health Equity in Clinical Trial Design

Author:

Brittany Gerald

Author:

Benjamin Young

Author:

Sandra Amaro

PREVIOUS INDUSTRY LEADING SPEAKERS

Monique Adams

Monique Adams

Monique Adams

Sandra Amaro

Sandra Amaro

Sandra Amaro

Tabia Henry Akintobi

Tabia Henry Akintobi

Tabia Henry Akintobi

Martin Mendoza

Martin Mendoza

Martin Mendoza

Rajbir Singh

Rajbir Singh

Rajbir Singh

Edie Stringfellow

Edie Stringfellow

Edie Stringfellow

Michel Reid

Michel Reid

Michel Reid

Kemi Willaims

Kemi Willaims

Kemi Willaims